Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
-
New shorter radiation course aims to ease sarcoma treatment for seniors
Disease control Recruiting nowThis study tests a shorter, higher-dose radiation therapy given over one week before surgery for soft tissue sarcoma in patients aged 70+ or those 65+ who are considered fragile. The goal is to see if this approach reduces major wound complications after surgery. About 48 partici…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Lymph node surgery may boost cervical cancer treatment
Disease control Recruiting nowThis study looks at whether surgically removing para-aortic lymph nodes before standard chemoradiation can improve disease-free survival in people with stage IIIC1 cervical cancer. About 510 participants will be randomly assigned to either standard treatment or surgery plus tailo…
Phase: PHASE3 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could extra chemo stop sarcoma from spreading?
Disease control Recruiting nowThis Phase 3 trial is testing whether adding four cycles of chemotherapy (doxorubicin-based) to standard surgery and radiation can improve outcomes for people with high-risk soft tissue sarcoma. The study will enroll 600 participants, with 250 high-risk patients randomly assigned…
Phase: PHASE3 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could less chemo be enough? new trial tests shorter treatment for head and neck cancer
Disease control Recruiting nowThis phase 2 trial is testing whether giving only 4 cycles of chemotherapy alongside the immunotherapy drug pembrolizumab can effectively treat PD-L1-positive head and neck cancer that has spread or come back. Standard treatment usually involves 6 cycles of chemo. The study will …
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Radiation boost may extend life for bladder cancer patients with few remaining tumors
Disease control Recruiting nowThis study tests whether adding focused radiation to standard treatment helps people with metastatic bladder cancer live longer. It includes patients whose cancer has not worsened after initial therapy and who have three or fewer remaining tumors. About 130 participants will be r…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New skin flap could reduce surgery side effects for head and neck cancer patients
Disease control Recruiting nowThis study tests a new surgical technique using a thin skin flap from the groin area to rebuild the mouth or throat after cancer removal. The goal is to see if it causes fewer problems at the donor site compared to standard flaps. Forty adults with head and neck cancer will be fo…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 26, 2026 17:27 UTC
-
Cancer care goes home: study tests nurse visits to cut hospital trips
Symptom relief Recruiting nowThis study is testing a new way to manage care for 33 cancer patients who take oral chemotherapy at home. Instead of going to the hospital every month just to pick up medicine, a nurse will visit them at home twice in six months. An advanced practice nurse will coordinate everyth…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can sexology consultations restore intimacy after throat cancer surgery?
Symptom relief Recruiting nowThis study tests whether a series of sexology consultations can help people who had their voice box removed due to throat cancer, along with their partners, feel better about their intimate lives. The program involves individual talks with a trained sexology nurse and questionnai…
Sponsor: Institut Claudius Regaud • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Hypnosis may calm cancer patients during radiation
Symptom relief Recruiting nowThis study looks at whether medical hypnosis can help reduce anxiety in people with solid tumors who are getting radiation therapy. About 45 moderately to very anxious patients will either listen to relaxing music alone or combine it with hypnosis during their sessions. The goal …
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Pre-surgery rehab boosts recovery in limb sarcoma patients, early trial suggests
Symptom relief Recruiting nowThis study tests whether a personalized program of exercise, nutrition advice, and mental support before surgery can improve recovery and quality of life in people with bone or soft-tissue sarcoma of the arm or leg. About 53 participants will be followed for two years after surge…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Symptom relief
Last updated Jun 26, 2026 17:04 UTC
-
Healthy volunteers help validate new blood tests for cancer detection
Knowledge-focused Recruiting nowThis study enrolls 68 healthy volunteers (cancer-free adults working at a French hospital) to help validate new blood-based DNA analysis methods. Participants give one blood sample, which is tested for cancer-related genetic mutations using advanced sequencing and PCR techniques.…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
770 cancer patients join study to unlock immunotherapy secrets
Knowledge-focused Recruiting nowThis study tracks 770 adults with advanced solid cancers (like lung, head and neck, melanoma, or bladder cancer) who are receiving immunotherapy. Researchers collect tumor and blood samples over time to find biological markers that predict how well the treatment works or causes s…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood test aims to spot hidden cancer cells in 9 tumor types
Knowledge-focused Recruiting nowThis study is looking for certain cells in the blood of people with 9 types of advanced cancers that have spread. Researchers will take one blood sample from each of 450 participants before they start a new treatment. They will use two different lab methods to see if they can fin…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI and big data join the fight against childhood brain cancer relapse
Knowledge-focused Recruiting nowThis study looks back at data from 370 children treated for ependymoma, a common brain tumor in kids. Even after surgery and radiation, about half of these tumors return. Researchers are using artificial intelligence to analyze medical images, genetics, and treatment records to f…
Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New blood test could spot cancer cells better in advanced breast and prostate cancer
Knowledge-focused Recruiting nowThis study compares three different blood tests (CellSearch, Parsortix, and SmartCatch) to see which one best detects circulating tumor cells in patients with metastatic breast or prostate cancer. Researchers will take blood samples from 54 patients before they start a new treatm…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Weight matters: new study tracks drug levels in breast cancer patients
Knowledge-focused Recruiting nowThis study is investigating whether a patient's body weight changes how the drug Trastuzumab-Deruxtecan (T-DXd) behaves in the body. Researchers will compare drug levels and side effects between normal-weight and overweight or obese patients with advanced breast cancer. The goal …
Phase: PHASE4 • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can herbs and supplements boost cancer pill adherence?
Knowledge-focused Recruiting nowThis study explores whether using alternative and complementary therapies, like turmeric supplements, affects how well early-stage breast cancer patients stick to their tamoxifen treatment. Researchers will follow 200 patients for one day to measure medication adherence and tamox…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New study tracks memory loss in kids after brain radiation
Knowledge-focused Recruiting nowThis study looks at how radiation to the brain affects memory in children who had a brain tumor. Researchers will test memory and thinking skills in 130 children ages 4 to 12, starting 2 years after radiation and again 2 years later. The goal is to learn which parts of the brain …
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Scientists hunt for biomarkers of PARP inhibitor resistance in BRCA breast cancer
Knowledge-focused Recruiting nowThis study is collecting tumor and blood samples from 120 people with advanced, HER2-negative breast cancer who have a BRCA1/2 mutation. Researchers want to see if certain DNA repair proteins (POLQ, Shieldin complex, 53BP1) can predict whether a tumor will resist PARP inhibitor d…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Can blood and tumor samples predict who responds to brain cancer therapy?
Knowledge-focused Recruiting nowThis study will collect blood and tumor samples from 80 people with newly diagnosed glioblastoma to find biological markers that show whether a treatment called TTFields (tumor-treating fields) is working. The goal is to understand why some patients respond and others don't. Part…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Scientists map fat and organelles in breast cancer cells to unlock subtype secrets
Knowledge-focused Recruiting nowThis study is collecting tumor samples from 1,050 people with early or metastatic breast cancer to analyze fat storage and organelle properties in cancer cells. Researchers aim to create a detailed atlas of these features across different breast cancer subtypes. The goal is to be…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Scientists launch deep dive into rare sarcomas to unlock immune secrets
Knowledge-focused Recruiting nowThis study is collecting tumor and blood samples from 400 people with rare soft tissue sarcomas to learn how their immune system reacts to the cancer. Researchers will also track patients' health over time to see how the disease progresses. The goal is to find clues that could le…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Scientists hunt for clues to predict cancer in people with rare gene mutation
Knowledge-focused Recruiting nowThis study follows 150 people with a GATA2 gene mutation to learn what factors predict if they will develop serious blood cancers like MDS or AML. Researchers will collect blood and bone marrow samples over 5 years and also review past data from 100 other patients. The goal is to…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Scientists track rare gene mutation to predict blood cancer in families
Knowledge-focused Recruiting nowThis study looks at families who carry a change in the DDX41 gene, which may raise the risk of blood cancers like leukemia. Researchers will collect health questionnaires and saliva samples from up to 910 people to track who develops blood problems and when. The goal is to better…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Blood test may spot ovarian cancer return before symptoms show
Knowledge-focused Recruiting nowThis study looks at whether a blood test can find genetic changes in tumor DNA that signal ovarian cancer is coming back. It involves 130 women with BRCA mutations who are taking a maintenance drug called Olaparib after initial treatment. The goal is to see if these blood tests c…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Blood test may predict who benefits from targeted radiation therapy
Knowledge-focused Recruiting nowThis study looks at whether an inflammation-based score (using CRP and albumin levels) can predict how well patients with advanced intestinal neuroendocrine tumors respond to Lu-177 oxodotreotide therapy. Researchers will follow 150 patients for 36 months, collecting blood sample…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Ovarian cancer resistance under the microscope: 600-Patient study launches
Knowledge-focused Recruiting nowThis study is looking at why some ovarian cancers become resistant to platinum-based chemotherapy, a common treatment. Researchers will collect blood, tumor, and fluid samples from 600 patients over five years, alongside their medical data. No new drugs are being tested—the goal …
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Simple blood test could replace some scans for prostate cancer patients
Knowledge-focused Recruiting nowThis study is testing whether a blood test can detect prostate cancer cells that have spread, similar to a special PET scan. Researchers will take blood samples from 80 prostate cancer patients before their PET scans and compare the results. If the blood test works well, it might…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Massive study aims to unlock Cancer's immune secrets
Knowledge-focused Recruiting nowThis study will collect blood and tumor samples from 1,100 people with various cancers, including head and neck, ovarian, cervical, lung, and brain cancers. Researchers want to learn how immune cells called T cells behave in these tumors. The goal is to better understand why some…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:24 UTC